1. Home
  2. MERLOT Materials
  3. Material Detail: FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

Material Detail

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

FDA approved Arexvy, the first RSV vaccine approved for use in the U.S. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV.

Keyword:
RSV
Disciplines:
Go to Material 
Bookmark / Add to Course ePortfolio
Create a Learning Exercise
Add Accessibility Information
Rate
Add a Comment

Quality

  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collection (1) Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Material Type:
Reference Material
Date Added to MERLOT:
November 1, 2023
Date Modified in MERLOT:
October 19, 2024
Author:
Unknown (Know the author?)
Submitter:
Mary Bemker
Primary Audience:
High School, College General Ed, College Lower Division, College Upper Division, Graduate School, Professional
Technical Format:
Website
Mobile Compatibility:
Not specified at this time
Technical Requirements:
accessed via a major browser
Language:
English
Cost Involved:
No
Source Code Available:
Yes
Creative Commons:
Unknown

Browse...

Disciplines with similar materials as FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
People who viewed this also viewed
Other materials like FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.